Atea Pharmaceuticals, Inc. Common Stock AVIR
$5.25
+5.21%
at last close
Market Cap$399.34 million
P/E Ratio—
Div Yield—
Volume265.0K
52-Week Range
$2.78$6.45
Key Stats
- Today's Range
- $4.97 – $5.30
- 50-Day Range
- $3.82 – $5.30
- 52-Week Range
- $2.78 – $6.45
- Volume
- 265K shs
- Average Volume
- 400K shs
- Market Cap
- $399.34 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.39%
- Days to Cover
- 1.46
About Atea Pharmaceuticals, Inc. Common Stock
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
Related Stocks
Compare head-to-head: AVIR vs LLY·AVIR vs JNJ·AVIR vs ABBV·AVIR vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.